Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Novartis Venture Fund

Status
ACTIVE
Global HQ
Basel, Switzerland
Countries of investment
  • Israel
  • USA
  • Canada
  • Switzerland
Investment stages
  • Seed
Industries
  • Pharmaceuticals
  • Biotechnology
  • Digital Health
About
Novartis Venture Fund is a leading venture capital firm dedicated to advancing the life sciences sector by strategically investing in innovative biotechnology and biopharmaceutical companies. With a keen focus on addressing unmet patient needs, the fund supports the development of groundbreaking therapeutics that can transform healthcare. By leveraging its extensive industry expertise and network, Novartis Venture Fund aims to foster innovation and drive significant advancements in medical science, ultimately improving patient outcomes worldwide. Through its investments, the fund seeks to catalyze the growth of pioneering companies poised to make a meaningful impact in the realm of healthcare.
Min check size
$1M
Max check size
$10M
Fund size
NPS

Investment Thesis

The Novartis Venture Fund was created to foster innovation, drive significant patient benefit, and generate superior returns by nurturing and investing in innovative life science companies.
Lead investor
Co Invest
Number of exits
Preferred contact method

Novartis Venture Fund Contacts Information

Primary contact

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp